Viralyzing transgenes to improve oncolytic immunotherapy
病毒裂解转基因以改善溶瘤免疫疗法
基本信息
- 批准号:472390
- 负责人:
- 金额:$ 7.29万
- 依托单位:
- 依托单位国家:加拿大
- 项目类别:Operating Grants
- 财政年份:2022
- 资助国家:加拿大
- 起止时间:2022-09-01 至 2023-09-01
- 项目状态:已结题
- 来源:
- 关键词:
项目摘要
Cancer killing viruses carry a "payload" as a form of a "transgene". This payload is critical for their anti-cancer efficacy. The transgene is often a carbon copy of a human gene, but we know that the human genetics is very different to that of a virus. T
致癌病毒携带一种“有效载荷”作为一种“转基因”。这种有效载荷对它们的抗癌效果至关重要。转基因通常是人类基因的复制品,但我们知道人类的基因与病毒的基因非常不同。T
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Alain Tommy其他文献
Alain Tommy的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Alain Tommy', 18)}}的其他基金
Viralyzing transgenes to improve oncolytic immunotherapy.
病毒裂解转基因以改善溶瘤免疫疗法。
- 批准号:
494929 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
Oral Administration of Reoviruses for the Treatment, Prevention and Early Diagnosis of Colorectal Cancer.
口服呼肠孤病毒用于治疗、预防和早期诊断结直肠癌。
- 批准号:
453445 - 财政年份:2021
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
Characterization of a new pharmao-viral approach for the treatment of brain cancer
治疗脑癌的新药物病毒方法的表征
- 批准号:
372713 - 财政年份:2017
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
相似海外基金
Development of a cancer immunoregenerative therapy that blocks function-suppressive RNA editing signals from cancer cells to immune cells.
开发一种癌症免疫再生疗法,阻断从癌细胞到免疫细胞的功能抑制性 RNA 编辑信号。
- 批准号:
23K08173 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Induction of Paraptosis in Cancer Cells by Triptycene-Peptide Hybrids and Its Mechanistic Study
三蝶烯肽杂交体诱导癌细胞凋亡及其机制研究
- 批准号:
23K06056 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (C)
Study on the Mechanisms of the Induction of Mesenchymal Cancer Cells and Their Plasticity and Diversity
间充质癌细胞诱导机制及其可塑性和多样性的研究
- 批准号:
23H05486 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Scientific Research (S)
Elucidation of molecular mechanisms of interaction between colorectal cancer cells and stromal cells in tumor budding area
阐明结直肠癌细胞与肿瘤出芽区基质细胞相互作用的分子机制
- 批准号:
23K15489 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
KRAS inhibitors prime cancer cells for macrophage-mediated destruction
KRAS 抑制剂可引发巨噬细胞介导的破坏癌细胞
- 批准号:
10638364 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Primary prostate cancer cells as novel models for patient therapy prediction
原发性前列腺癌细胞作为患者治疗预测的新模型
- 批准号:
477987 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Operating Grants
Development of fluorescence imaging technology of LAT1-expressing cancer cells using intracellular click reaction
利用细胞内点击反应开发表达 LAT1 的癌细胞荧光成像技术
- 批准号:
23KJ0588 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for JSPS Fellows
Development of anticancer drug candidates from natural products target for pancreatic cancer cells
从天然产物中开发针对胰腺癌细胞的抗癌候选药物
- 批准号:
23K14377 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Elucidation of the acquisition mechanism of radiation resistance of cancer cells by changes in osmotic pressure and its application to radiotherapy
通过渗透压变化阐明癌细胞耐辐射能力的获得机制及其在放射治疗中的应用
- 批准号:
23K14929 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别:
Grant-in-Aid for Early-Career Scientists
Fibroblasts Support the Growth of Brain Metastasis by Rendering Cancer Cells Resistant to Chemotherapy and Inducing Immunosuppression in Tumor Microenvironment
成纤维细胞通过使癌细胞对化疗产生抵抗并在肿瘤微环境中诱导免疫抑制来支持脑转移瘤的生长
- 批准号:
10735448 - 财政年份:2023
- 资助金额:
$ 7.29万 - 项目类别: